RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. A live and archived w ...

Key Points D-Wave stock rose for a second straight day on Thursday. On Tuesday, the company announced a successful pilot project with the North Wales Police in Britain. 10 stocks we like better than D-Wave Quantum › Shares of quantum computing company D-Wave Quantum (NYSE: QBTS) soared 11.5% through 10:40 a.m. ET Thursday -- all on no obvious news today. D-Wave Quantum did have some news earlier in the week. It may be one reason why the quantum stock has risen the past two days, despite investor u ...

Ciena Corporation (NYSE:CIEN) is one of the best smart city stocks. On September 26, Stifel kept its Buy rating and $152 price target on Ciena, whose shares are trading near a 52-week high and indicate a jump of roughly 120% in the last year. Ciena is expected to maintain robust revenue growth with improved profitability metrics, according to Stifel, especially when keeping in mind the company’s almost 13% growth in the last year. Stifel Keeps Buy Rating On Ciena (CIEN), Price Target At $152 Photo by Mo ...

ANTIOCH, Tenn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) today announced it has completed its previously announced agreement to sell its Self Service segment (“Pick Your Part”) to an affiliate of Pacific Avenue Capital Partners, LLC for an enterprise value of $410 million, subject to customary purchase price adjustments. Justin Jude, President and Chief Executive Officer, commented, “We are executing on our strategic priorities by simplifying our portfolio of businesses and continuing ...

Core Insights - Curtiss-Wright Corporation (NYSE:CW) is recognized as one of the 10 Best Defense Contractor Stocks to Buy Now, highlighting its significant upside potential [1] Financial Performance - On September 15, 2025, Curtiss-Wright Corporation reached a record high stock price of $518.00, reflecting a year-to-date return of 46.03% and a 55.98% return over the past year [2] Dividend and Share Repurchase - The company has maintained dividend payments for 52 consecutive years, recently increasing its payout by 14.3%. A quarterly dividend of $0.24 per share has been declared, payable on October 10, 2025 [3] - On September 10, 2025, the company expanded its share repurchase program by $200 million, bringing the total for the year to over $450 million, reinforcing its commitment to long-term value creation [3][4] Strategic Initiatives - The expanded buyback program supports Curtiss-Wright's "Pivot to Growth" strategy and positions the company for record annual repurchases in 2025 [4] - Curtiss-Wright Corporation provides engineered products, solutions, and services across aerospace and defense, commercial power, process, and industrial markets globally [4]

Group 1 - Curtiss-Wright Corporation (CW) is recognized as one of the 10 Best Defense Contractor Stocks to Buy Now, highlighting its significant upside potential [1] - On September 15, 2025, CW reached a record high stock price of $518.00, reflecting a year-to-date return of 46.03% and a 55.98% return over the past year [2] - The company has maintained dividend payments for 52 consecutive years, recently increasing its payout by 14.3%, and declared a quarterly dividend of $0.24 per share, payable on October 10, 2025 [3] Group 2 - CW expanded its 2025 share repurchase program by $200 million, bringing the total to over $450 million for the year, reinforcing its commitment to long-term value creation [3][4] - The expanded buyback supports CW's "Pivot to Growth" strategy and positions the company for record annual repurchases in 2025 [4] - CW provides engineered products, solutions, and services to various markets, including aerospace and defense, commercial power, process, and industrial sectors globally [4]

Core Viewpoint - NIKE, Inc. is expected to report a significant decline in earnings per share (EPS) for the fiscal first quarter of 2026, reflecting ongoing challenges in the market and competition, particularly in Greater China [2][5]. Financial Performance - NIKE is projected to report a profit of $0.28 per share on a diluted basis for Q1 2026, down 60% from $0.70 per share in the same quarter last year [2]. - For the full fiscal year 2026, analysts expect an EPS of $1.68, which represents a 22.2% decrease from $2.16 in fiscal 2025 [3]. - However, EPS is anticipated to rebound significantly to $2.59 in fiscal 2027, marking a year-over-year increase of 54.2% [3]. Stock Performance - Over the past 52 weeks, NIKE's stock has underperformed, declining by 21.3%, while the S&P 500 Index has gained 15.4% [4]. - The stock has also lagged behind the Consumer Discretionary Select Sector SPDR Fund, which saw an 18.3% increase during the same period [4]. Market Challenges - NIKE's struggles are attributed to several factors, including a lack of innovation, reduced reliance on third-party sellers, and intense competition from domestic brands in Greater China, such as Anta and Li-Ning [5]. - U.S. tariffs have further complicated sourcing from China and other manufacturing hubs like Vietnam [5]. Analyst Sentiment - The consensus opinion among analysts is moderately bullish, with a "Moderate Buy" rating overall. Out of 36 analysts, 15 recommend a "Strong Buy," four suggest a "Moderate Buy," 15 give a "Hold," and two recommend a "Strong Sell" [7]. - The average analyst price target for NIKE is $80.56, indicating a potential upside of 16.3% from current levels [7].

ANTIOCH, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) will release its third quarter 2025 financial results on Thursday, October 30, 2025. Conference Call Details LKQ will host a conference call and webcast on October 30, 2025 at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) with members of senior management to discuss the Company's results. To access the investor conference call, please dial (833) 470-1428. International access to the call may be obtained by dialing (404) 975-4 ...

Group 1 - Mairs & Power Balanced Fund reported a return of 2.66% in the first half of 2025, underperforming benchmark indexes which rose 5.43% and 5.67% respectively [1] - The fund's performance was impacted by external factors such as tariff uncertainty, conflicts in the Middle East, and rising national debt [1] - The fund experienced a recovery, rising 25% from its low at the beginning of the quarter [1] Group 2 - Bio-Techne Corporation (NASDAQ:TECH) has a market capitalization of $8.239 billion and focuses on life science reagents, instruments, and services [2] - The stock of Bio-Techne Corporation saw a one-month return of -5.87% and a 52-week decline of 29.39%, closing at $52.92 per share on September 23, 2025 [2] - The company underperformed due to uncertainty in the funding environment, influenced by federal funding cuts and a weak venture capital landscape [3] Group 3 - Bio-Techne Corporation generated $317 million in revenues in the fiscal fourth quarter of 2025, reflecting a 3% year-over-year increase on an organic basis and a 4% increase on a reported basis [4] - The company is not among the 30 most popular stocks among hedge funds, with 37 hedge fund portfolios holding its stock at the end of the second quarter, up from 34 in the previous quarter [4] - Despite acknowledging Bio-Techne's potential, the company believes certain AI stocks present greater upside potential and lower downside risk [4]

Company Overview - Bio-Techne Corporation (TECH) is headquartered in Minneapolis, Minnesota, and specializes in developing, manufacturing, and selling life science reagents, instruments, and services for research, diagnostics, and bioprocessing markets, with a market cap of $8.3 billion [1] - The company focuses on proteins, cytokines, growth factors, immunoassays, and small molecules, positioning itself as a significant player in the biotechnology industry [1] Market Position - TECH is classified as a mid-cap stock, with a market cap exceeding $2 billion, highlighting its size, influence, and dominance within the biotechnology sector [2] - The company is committed to innovation, strategic acquisitions, and has a global presence, which positions it for continued success and growth opportunities both domestically and internationally [2] Stock Performance - Despite its strengths, TECH's stock has decreased by 34.5% from its 52-week high of $80.80, reached on November 6, 2024 [3] - Over the past three months, TECH stock gained 7.3%, underperforming the Dow Jones Industrials Average, which gained 8.7% during the same period [3] - Year-to-date, shares of TECH have dipped 26.5%, and over the past 52 weeks, they have fallen 31.5%, significantly underperforming the Dow Jones Industrials Average's YTD gains of 8.8% and 9.9% returns over the last year [4] Recent Financial Results - On August 6, TECH reported its Q4 results, with an adjusted EPS of $0.53, surpassing Wall Street expectations of $0.50, and revenue of $317 million, exceeding forecasts of $315.4 million [5] - In comparison, Adaptive Biotechnologies Corporation (ADPT) has shown significant resilience, with YTD gains of 132.4% and 227% returns over the past 52 weeks, indicating a competitive challenge for TECH [5]